Free Trial
NASDAQ:CYRX

CryoPort Q3 2026 Earnings Report

CryoPort logo
$18.14 +0.71 (+4.07%)
Closing price 10/5/2026 04:00 PM Eastern
Extended Trading
$18.16 +0.02 (+0.11%)
As of 08:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CryoPort EPS Results

Actual EPS
N/A
Consensus EPS
-$0.19
Beat/Miss
N/A
One Year Ago EPS
N/A

CryoPort Revenue Results

Actual Revenue
N/A
Expected Revenue
$48.69 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

CryoPort Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Tuesday, November 3, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

CryoPort Earnings Headlines

Danaher (NYSE:DHR) vs. CryoPort (NASDAQ:CYRX) Head-To-Head Analysis
Feds Say Your Cash Isn’t Property—Can They Take It?
The Department of Justice recently argued in court that cash may not qualify as legal property. That raises new questions about how protected everyday bank accounts and retirement savings really are.tc pixel
Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals
BTIG Remains a Buy on CryoPort (CYRX)
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
See More CryoPort Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CryoPort? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CryoPort and other key companies, straight to your email.

About CryoPort

CryoPort (NASDAQ:CYRX) is a life sciences logistics company that provides temperature-controlled supply chain solutions for the development, manufacture and delivery of advanced therapies, biologics and other temperature-sensitive materials. Its services are used in areas including cell and gene therapy, regenerative medicine, pharmaceuticals, clinical research and reproductive medicine.

The company offers specialized shipping systems, cryogenic storage and monitoring technologies, logistics coordination, inventory management and related support services. Its solutions are designed to maintain the required temperature and handling conditions for biological materials throughout transportation and storage, from collection and manufacturing sites to clinical locations and treatment centers.

CryoPort serves customers internationally through a network of facilities, logistics providers and operating companies. Its portfolio has expanded through acquisitions and includes businesses involved in cryogenic equipment, biostorage, cell and gene therapy logistics, and temperature-monitoring technologies. The company is headquartered in Nashville, Tennessee, and its common stock trades on the Nasdaq under the symbol CYRX.

View CryoPort Profile